Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1345/aph.1E520 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Medication-Seeking Behaviors and Correlated Characteristics of Zolpidem Users in Taiwan-A Shared Patient Network Analysis.
Healthcare (Basel)
March 2024
Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.
Increasing insomnia signals a public health problem, alongside rising zolpidem use. This study investigates the factors behind the disproportionate rise in zolpidem prescriptions in Taiwan. It aims to identify the determinants of high-dose zolpidem users in Taiwan's Yilan County and employ an innovative approach to outline their medication-seeking patterns, using Taiwan's healthcare database.
View Article and Find Full Text PDFAbrupt Withdrawal From Chronic High-Dose Zolpidem Use: A Case Report of Resulting Delirium.
Cureus
November 2023
General Medicine, Matra Chhaya Medical Center, Kanpur, IND.
We report the case of a male in his twenties who was prescribed 10 mg of zolpidem daily for sleep disturbances. Within one month, he self-augmented the dose to 30 mg daily. Unable to secure an authorized refill, he sought unauthorized suppliers and increased his daily intake to 70 mg over eight months.
View Article and Find Full Text PDFSevere chronic abuse of zolpidem for over 10 years: a case report and review of similar cases.
Front Psychiatry
September 2023
Research Center for Psychiatry and Behavior Science, Shiraz University of Medical Sciences, Shiraz, Iran.
Background: Insomnia is a major health issue, and zolpidem is an effective treatment for insomnia. However, high doses of zolpidem can cause dependence, abuse, and withdrawal symptoms, questioning its advantages.
Case Presentation: A 39-year-old woman who has been divorced and unemployed for 2 years was referred to an addiction treatment center with a chief complaint of "seizure-like withdrawal symptoms after consuming high doses of zolpidem (up to 6,000 mg per day) for a decade.
Zolpidem in Elderly Patients With Acute Treatment Resistant Catatonia: A Case Report.
Hosp Pharm
October 2023
Rush University Medical Center, Chicago, IL, USA.
Article Synopsis
- Catatonia is diagnosed by the presence of three or more symptoms, including catalepsy and mutism, as defined by the DSM-5.
- Screening tools like the Bush Francis Catatonia Rating Scale (BFCRS) help assess and monitor symptoms.
- Lorazepam is the primary treatment for catatonia, but in cases where patients don't respond, alternative treatments like high-dose zolpidem may be used, especially when ECT is not an option due to cardiac concerns.
Case Report: High doses of Zolpidem and QT interval lengthening: Is there a relationship? A case series.
Front Psychiatry
October 2022
Unit of Addiction Medicine, Department of Internal Medicine, G.B. Rossi Hospital, Verona, Italy.
Zolpidem is indicated in cases of severe insomnia in adults and, as for BDZs, its assumption should be limited to short periods under close medical supervision. Since several drugs cause corrected QT interval (QTc) elongation, the authors investigated whether high daily doses of Zolpidem could cause QTc elongation. The study was conducted in the Addiction Medicine Unit of the G.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!